rs281864970
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_024312.5(GNPTAB):c.1001G>T(p.Arg334Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R334P) has been classified as Pathogenic.
Frequency
Consequence
NM_024312.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.1001G>T | p.Arg334Leu | missense_variant | 9/21 | ENST00000299314.12 | NP_077288.2 | |
GNPTAB | XM_011538731.3 | c.920G>T | p.Arg307Leu | missense_variant | 9/21 | XP_011537033.1 | ||
GNPTAB | XM_006719593.4 | c.1001G>T | p.Arg334Leu | missense_variant | 9/19 | XP_006719656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPTAB | ENST00000299314.12 | c.1001G>T | p.Arg334Leu | missense_variant | 9/21 | 1 | NM_024312.5 | ENSP00000299314 | P1 | |
GNPTAB | ENST00000549940.5 | c.1001G>T | p.Arg334Leu | missense_variant | 9/11 | 1 | ENSP00000449150 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460664Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726778
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 12, 2019 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg334 amino acid residue in GNPTAB. Other variant(s) that disrupt this residue have been observed in individuals with GNPTAB-related conditions (PMID: 29872134, 19617216), which suggests that this may be a clinically significant amino acid residue. This variant has been reported to affect GNPTAB protein function (PMID: 25505245). This variant has been observed in individual(s) with GNPTAB-related conditions (PMID: 19197337). ClinVar contains an entry for this variant (Variation ID: 39019). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with leucine at codon 334 of the GNPTAB protein (p.Arg334Leu). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and leucine. - |
Mucolipidosis type II Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at